Macquarie Emerging Markets Fund A

The fund invests primarily in a broad range of equity securities of companies located in emerging market countries. Emerging market countries include those currently considered to be developing by the World Bank, the United Nations, or the countries' governments. These countries typically are located in the Asia-Pacific region, Eastern Europe, the Middle East, Central America, South America, and Africa. Under normal circumstances, at least 80% of the fund's net assets, plus any borrowings for investment purposes, will be invested in emerging market issuers (80% policy).

Macquarie Emerging Markets Fund A trades as DEMAX on NASDAQ. The company is classified in Financial Services / Asset Management and reports in USD.

The current profile places the business in Asset Management. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Detailed operating-segment data is not available for this symbol yet.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Macquarie Emerging Markets Fund A can be compared against peers such as Baillie Gifford Emerging Markets Equities Fund Class K, Fidelity Freedom Index 2020 Fund - Investor Class, Pioneer Fundamental Growth Fund Class Y, Fidelity Advisor International Growth Fund Class Z, The Hartford Growth Opportunities Fund Class A, The Hartford Growth Opportunities Fund Class R4.

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $18.19B, beta of 1.98, and return on equity of N/A.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

DEMAX currently shows total debt of N/A and beta of 1.98. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

Recent filings to review: 497 (2026-04-30 00:00:00), NPORT-P (2026-04-23 00:00:00), 497J (2026-04-06 00:00:00), 497 (2026-04-06 00:00:00).

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.macquarie.com/au/en/investors.html

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.